IMRIS
IMRIS designs and manufactures the world's only ceiling-mounted intraoperative MRI surgical suites, enabling real-time brain imaging during neurosurgery without moving the patient. The private company serves 100+ hospital and academic medical center customers globally.
- Company typePrivate
- Founded2005
- HeadquartersMinnetonka, United States
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What IMRIS does
IMRIS designs, manufactures, and services the world's only ceiling-mounted intraoperative MRI (iMRI) surgical suites, in which a high-field MR scanner (1.5T or 3T) travels on a rail system between a diagnostic room and adjacent operating rooms so the patient remains stationary while real-time imaging is performed during neurosurgical procedures. The core product is the InVision Operating Suite, supported by proprietary accessories including the ORT-400 neurosurgical table, HFD100 head fixation device, horseshoe headrest system, and HC150/HC300 imaging coils. The company was founded in 2005, is headquartered in Chaska, Minnesota, and was taken private by Grovecourt Capital Partners in February 2025.
IMRIS sells custom-designed, multi-room surgical theatres directly to large hospital systems, academic medical centers, and cancer centers through an enterprise field sales motion with regional offices in the United States, Germany, China, and Australia, supplemented by channel distributors such as Gulf Medical Company in Saudi Arabia. Revenue is generated primarily through one-time capital equipment sales of complex multi-room installations plus recurring service, support, and clinical training contracts. The 2022 acquisition of Superconducting Systems Inc. (SSI) added a parallel business in cryogen-free superconducting magnets for NMR spectroscopy, preclinical MRI, and human imaging research applications. As of the input data, IMRIS reports over 100 customers globally, more than 75 cumulative installations, and over 70,000 patients treated across flagship sites including Boston Children's Hospital, Memorial Sloan Kettering, MedStar Georgetown, Uppsala University Hospital, Xuanwu Hospital in China, and Prince Sultan Military Medical City in Saudi Arabia.
The company maintains an active technology roadmap including FDA 510(k) clearances for the iMRI 3T-V (2021), InVision 1.5 Surgical Theatre (2024), and InVision 3T Recharge Operating Suite (2025), a longstanding Siemens Healthineers collaboration for BioMatrix 3T integration, and a January 2026 strategic AI imaging partnership with SpinTech MRI. New CEO Shalabh Chandra was appointed in September 2025 to lead the next phase of growth under PE ownership.
IMRIS firmographics
Firmographics- Name
- IMRIS
- Legal name
- IMRIS Imaging, Inc.
- Website
- https://imris.com
- Company type
- Private
- Founded year
- 2005
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- IMRIS designs and manufactures the world's only ceiling-mounted intraoperative MRI surgical suites, enabling real-time brain imaging during neurosurgery without moving the patient. The private company serves 100+ hospital and academic medical center customers globally.
- Ownership category
- akta.pro rank
IMRIS industry classification
Industry- Product category
- Intraoperative MRI Surgical Equipment
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Irradiation Apparatus Manufacturing (334517), Surgical Appliance and Supplies Manufacturing (339113)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Intraoperative Imaging & Guidance (C-arms, O-arm, IOUS, fluorescence) (HLAHADAH)
- akta.pro secondary industries
- Magnetic Resonance Imaging (MRI) Systems (HLAHABAC), Surgical Navigation, Tracking & Intraoperative Guidance (Ortho/Neuro/ENT) (HLAHADAG)
Keywords
Where IMRIS is headquartered
LocationHeadquarters
- HQ city
- Minnetonka
- HQ country
- United States
- HQ region
- North America
Offices4 records
Markets served
IMRIS business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Infrastructure
Revenue model
- Intraoperative MRI Surgical Suite Sales and Installation: IMRIS designs, manufactures, installs, and services proprietary intraoperative MRI surgical suites for hospitals and cancer centers. Revenue is generated through the sale and installation of custom-designed multi-room surgical suites incorporating ceiling-mounted moving MRI technology, along with ongoing service and support contracts.
- Service, Support, and Clinical Training: IMRIS provides comprehensive customer support including 24/7 customer service, on-site support, clinical workflow and safety training, and ongoing system maintenance to maximize uptime of IMRIS Operating Suites.
- Proprietary Surgical Products: IMRIS designs and manufactures proprietary head fixation devices, imaging coils, and OR tables for use in the intraoperative environment. Products are sold globally to clinical centers.
- SSI Cryogen-Free Magnet Products (via subsidiary): SSI designs and manufactures cryogen-free superconducting magnets for medical and research applications, sold to MRI system manufacturers and research institutions globally.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Multi-year contract | Custom Surgical Suite Configuration |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels5 records
IMRIS product offering
Product offeringCore offering
IMRIS designs, manufactures, installs, and services proprietary intraoperative MRI (iMRI) surgical suites — the InVision Operating Suite — featuring a ceiling-mounted magnet that travels on a rail system between a diagnostic room and adjacent operating rooms, bringing the MRI directly to the patient. The portfolio includes 1.5T and 3T systems based on Siemens MAGNETOM Vida technology, plus proprietary head fixation devices, MR-conditional surgical tables, imaging coils, and headrests. Through its subsidiary Superconducting Systems Inc. (SSI), IMRIS also produces cryogen-free superconducting magnets for medical and research applications.
Product overview
IMRIS is the global leader in intraoperative MRI surgical theatres, offering a comprehensive portfolio centered on the InVision Operating Suite platform. The core offering includes ceiling-mounted intraoperative MRI systems (available in 1.5T and 3T configurations) that travel on rail systems between diagnostic and operating rooms. Supporting accessories include the ORT-400 Neurosurgical Table, HFD100 Head Fixation Device, Horseshoe Headrest System, and HC150/HC300 Imaging Coils. Following the 2022 acquisition of Superconducting Systems Inc. (SSI), the portfolio expanded to include cryogen-free superconducting magnets for NMR spectroscopy, preclinical MRI, and human imaging research applications. The company serves neurosurgical, spinal, cardiovascular, and orthopedic markets globally.
Differentiator
Problem solved
Functional benefit
Products and services
- InVision Operating Suite IMRIS's flagship ceiling-mounted intraoperative MRI surgical theatre — the only iMRI system in the world that travels on a ceiling-mounted rail system between a diagnostic room and adjacent operating rooms, bringing the MRI directly to the patient. Available in 1.5T and 3T configurations.
- Intraoperative MRI System Custom-designed intraoperative MRI systems specifically for imaging during neurosurgical procedures, featuring high-field MR scanners that travel into operating rooms on demand.
- ORT-400 Neurosurgical Table (MR17) MR-conditional neurosurgical table designed specifically for optimal patient positioning and intraoperative imaging in hybrid operating rooms. Integrates with the IMRIS Head Fixation portfolio.
- HFD100 Head Fixation Device Proprietary head fixation device designed for use during intraoperative imaging, providing secure positioning for neurosurgical procedures.
- Horseshoe Headrest System Enables surgeons to position a patient without using a rigid head fixation device, designed for use with head sizes ranging from pediatric to adult-sized patients.
- HC150 and HC300 Imaging Coils Flexible intraoperative imaging coils designed for diagnostic-quality MR imaging of the head in pediatric and adult patients in prone, lateral, and supine positions. HC150 for 1.5T and HC300 for 3T systems, each with 8 channels (4 anterior + 4 posterior).
- SSI Cryogen-Free Superconducting Magnets SSI designs and manufactures cryogen-free (liquid helium free) superconducting magnets for medical and research applications. Magnet portfolio includes NMR spectroscopy magnets (7T to 9.4T), preclinical MRI magnets (1.5T to 7T), and human imaging research magnets. Acquired by IMRIS in September 2022 to vertically integrate magnet technology.
- InVision 1.5 Surgical Theatre FDA-cleared 1.5T ceiling-mounted intraoperative MRI system for neurosurgical applications, expanding the IMRIS product portfolio with a lower-field-strength option complementing the 3T systems.
- InVision 3T Recharge Operating Suite FDA 510(k) cleared 3T rechargeable operating suite for neurosurgical applications; the latest generation of IMRIS intraoperative imaging technology.
- DORO LUCENT iMRI Set IMRIS Cranial stabilization system co-launched with Black Forest Medical Group for intraoperative MRI imaging in neurosurgical applications. Compatible with all image-guided surgery systems with lightweight, slim design and adjustable DORO LUCENT iMRI Coil Connector IMRIS interface.
Quantifiable outcome
- Over 70,000 patients have benefited from image-guided therapy solutions integrated into the InVision Operating Suite since 2005.
- +5 more outcomes
Companies that use IMRIS
Customer profileNamed customers9 records
Segments3 records
Ideal customer profiles2 records
IMRIS technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration3 records
AI capability3 records
Feature9 records
IMRIS partnerships and signals
Strategic signalPartnerships
Nine partnerships are on record, tiered secondary and core.
- Nanalysis Scientific Corp.secondaryNanalysis Scientific Corp. has an expanded collaboration with IMRIS for magnetic resonance market opportunities, including the supply of NMR spectrometers and magnetic resonance electronics supporting IMRIS's intraoperative MRI platform.
- SpinTech MRIcoreIMRIS and SpinTech MRI announced a strategic collaboration to integrate SpinTech's STAGE AI-powered neuro-imaging software into the IMRIS InVision Surgical Theatre platform. The combined solution leverages IMRIS's moving-magnet iMRI system with SpinTech's software, which has been shown to reduce MRI brain exam times by approximately 30% while delivering enhanced 3T-quality resolution from 1.5T systems. The integrated solution is initially available to IMRIS customers in the United States for complex neurosurgical cases including tumor resections and epilepsy treatments.
- InsighteccoreIMRIS and Insightec entered into a collaboration agreement enabling Insightec's Exablate Neuro focused ultrasound systems to seamlessly operate within IMRIS InVision Surgical Theatres. The collaboration focuses on system validation across various IMRIS suite configurations and optimization of signal, electrical interfacing, and procedural workflow. This enables hospitals and physicians to expand treatment capabilities using focused ultrasound for neurological disorders such as essential tremor and Parkinson's disease.
- Black Forest Medical GroupcoreIMRIS and Black Forest Medical Group co-launched the DORO LUCENT iMRI Set IMRIS, a cranial stabilization system enabling intraoperative MRI imaging in neurosurgical applications. The system is compatible with all image-guided surgery systems from leading companies and features a lightweight, slim design with continuously adjustable DORO LUCENT iMRI Coil Connector IMRIS interface for precise positioning. The system is FDA and MDR compliant.
- Superconducting Systems Inc. (SSI)coreIMRIS acquired Superconducting Systems Inc. (SSI), a company that designs and develops cryogen-free (liquid helium free) superconducting magnets for medical and research applications. SSI magnets are used in commercial MRI systems throughout the world. SSI CEO Dr. Shahin Pourrahimi continues as President of SSI. The acquisition enables IMRIS to vertically integrate superconducting magnet technology into its intraoperative MRI systems.
- ETS-LindgrensecondaryETS-Lindgren serves as IMRIS's partner for electromagnetic and acoustic energy measurement and shielding systems, which are essential for RF shielding in IMRIS Surgical Theatres. ETS-Lindgren is recognized as the leading supplier of energy management solutions for industrial and commercial markets with over 75 years of innovation.
- Gulf Medical CompanysecondaryGulf Medical Company is the exclusive distributor for IMRIS products in Saudi Arabia, facilitating the installation of the first IMRIS Surgical Theatre at Prince Sultan Military Medical City. Gulf Medical is one of the largest distributors in Saudi Arabia with extensive experience in large, turnkey hospital projects.
- Siemens HealthineerscoreIMRIS and Siemens Healthineers strengthened their longstanding collaboration to expand customer access to MRI, CT, and Angiography imaging technology in hybrid OR neurosurgical market. IMRIS supports the sales of both IMRIS ceiling-mounted and Siemens Healthineers fixed options for imaging modalities. The iMRI 3T-V Surgical System is based on Siemens MAGNETOM Vida with BioMatrix Technology. Collaboration aims to address the growing multimodality hybrid OR market.
- Hill-Rom (Trumpf Medical)secondaryIMRIS and Hill-Rom (Trumpf Medical) co-developed the TruSystem 7500 MR Neuro Surgical Table, integrating IMRIS's MR Neuro OR Tabletop with Hill-Rom's TruSystem 7500 surgical table platform. The table is MR-conditional and specifically engineered for the IMRIS Surgical Theatre environment, supporting optimal patient positioning. Hill-Rom is a global medical technology leader with 10,000+ employees.
Scale indicators6 records
Recent moves8 records
Expansion highlights6 records
IMRIS competitors and assessment
Company assessmentBroad incumbents
- Medtronic: Diversified medical device leader with the StealthStation surgical navigation franchise serving neurosurgery, spine, and ENT. Comparable to IMRIS as a dominant incumbent in image-guided neurosurgery, though Medtronic is broader and not an iMRI provider.
- GE HealthCare: Large medical imaging manufacturer with a full MRI portfolio (including surgical and intraoperative variants) and hybrid OR offerings. Comparable as a broad incumbent competing in neurosurgical and intraoperative imaging markets served by IMRIS.
- Siemens Healthineers: Major MRI, CT, and angiography manufacturer and IMRIS's primary hardware partner (MAGNETOM Vida-based 3T-V system). Comparable as a broad incumbent in the imaging and hybrid OR market, while also being a strategic partner for IMRIS.
- Stryker: Global medical technology company with a Surgical Navigation and Robotics portfolio targeting neurosurgery, spine, and orthopedics. Comparable as a broad incumbent competing for hybrid OR and surgical guidance capital spend, though Stryker's iMRI presence is limited.
- Philips Healthcare: Global health technology company with MRI systems, hybrid OR, and image-guided therapy solutions. Comparable as a broad incumbent in intraoperative and hybrid OR imaging, competing for the same hospital capital wallet as IMRIS.
Emerging players
- Zimmer Biomet: Orthopedic and surgical technology company with the ROSA robotics platform extending into spine and neurosurgery. Comparable as an emerging image-guided and robotic neurosurgery player adjacent to IMRIS's image-guided therapy focus.
- Surgical Theater: Medtech company offering VR-based surgical planning and visualization that integrates with IMRIS-style intraoperative environments. Comparable as an emerging software/visualization ecosystem participant adjacent to IMRIS's image-guided therapy platform.
- Renishaw: UK-based engineering company with a Neuromate stereotactic neurosurgical robot and MRI-compatible components. Comparable as an emerging image-guided neurosurgery hardware supplier with overlap in intraoperative cranial procedures.
Direct peers
- Brainlab: Munich-based developer of surgical navigation, intraoperative imaging, and digital OR platforms for neurosurgery, spine, and other specialties. Closely comparable to IMRIS as a competitor for hybrid OR and image-guided neurosurgery capital budgets.
- Synaptive Medical: Toronto-based medical device company developing intraoperative MRI, surgical visualization, and connected neurosurgery tools. Directly comparable to IMRIS as a focused intraoperative MRI and image-guided neurosurgery pure-play.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
IMRIS social profiles
Digital presenceIMRIS compliance and trust
Trust signalCompliance2 records
IMRIS financial estimates
Financial estimateRevenue estimate
Valuation estimate
IMRIS leadership team
Management profileNumber of profiles
Profiles10 records
IMRIS subsidiaries and ownership
Company hierarchySubsidiaries1 record
IMRIS funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
IMRIS M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about IMRIS
What does IMRIS do?
IMRIS designs, manufactures, installs, and services proprietary intraoperative MRI (iMRI) surgical suites — the InVision Operating Suite — featuring a ceiling-mounted magnet that travels on a rail system between a diagnostic room and adjacent operating rooms, bringing the MRI directly to the patient. The portfolio includes 1.5T and 3T systems based on Siemens MAGNETOM Vida technology, plus proprietary head fixation devices, MR-conditional surgical tables, imaging coils, and headrests. Through its subsidiary Superconducting Systems Inc. (SSI), IMRIS also produces cryogen-free superconducting magnets for medical and research applications.
Is IMRIS a public or private company?
IMRIS is a private company. It is classified as private equity controlled and is currently operating.
When was IMRIS founded?
IMRIS was founded in 2005. It employs 101 to 250 people.
Where is IMRIS based?
IMRIS is headquartered in Minnetonka, United States, in the North America region.
How does IMRIS make money?
Four revenue lines are on record. Intraoperative MRI Surgical Suite Sales and Installation is the primary driver. The others are service, Support, and Clinical Training, proprietary Surgical Products and SSI Cryogen-Free Magnet Products (via subsidiary).
Who are IMRIS's main competitors?
Broad incumbents on record are Medtronic, GE HealthCare, Siemens Healthineers, Stryker and Philips Healthcare. Emerging players are Zimmer Biomet, Surgical Theater and Renishaw. Direct peers are Brainlab and Synaptive Medical.
Does IMRIS have an API?
No public API is recorded for IMRIS.
What industry is IMRIS in?
IMRIS's product category is Intraoperative MRI Surgical Equipment. Its primary akta.pro industry code is HLAHADAH, Intraoperative Imaging & Guidance (C-arms, O-arm, IOUS, fluorescence), with a secondary code of HLAHABAC, Magnetic Resonance Imaging (MRI) Systems. Its NAICS code is 334510 and its SIC code is 3845.